NCT03225729 (CBT-EC2) is a NA clinical trial of CRYOBEAUTY MAINS ET DECOLLETE in Solar Lentigo, sponsored by Cryobeauty.

Who is sponsoring NCT03225729?

NCT03225729 is sponsored by Cryobeauty.

What drugs are being tested in NCT03225729?

Interventions in NCT03225729: CRYOBEAUTY MAINS ET DECOLLETE, Liquid nitrogen.

What condition does NCT03225729 study?

NCT03225729 studies Solar Lentigo.

Is NCT03225729 still recruiting?

NCT03225729 is currently completed. Last updated 4 January 2018.

Last reviewed 2018-01-04 · How we verify

NCT03225729: CBT-EC2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of CRYOBEAUTY MAINS ET DECOLLETE Versus Liquid Nitrogen Cryotherapy, in the Treatment of Solar Lentigines

Completed NA Last updated 4 January 2018

What this trial tests

NA trial testing CRYOBEAUTY MAINS ET DECOLLETE in Solar Lentigo in 30 participants. Completed in 22 December 2017.

Timeline

25 October 2017

Primary endpoint
22 December 2017

22 December 2017

Quick facts

Lead sponsor	Cryobeauty
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	30
Start date	25 October 2017
Primary completion	22 December 2017
Estimated completion	22 December 2017
Sites	1 location across France

Drugs / interventions tested

CRYOBEAUTY MAINS ET DECOLLETE
Liquid nitrogen — full drug profile →

Conditions studied

Solar Lentigo — all drugs for Solar Lentigo →

Sponsor

Cryobeauty

Who can join

Adults 30 to 75, any sex, with Solar Lentigo. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the performance of new technology "CRYOTHERAPY MAINS ET DECOLLETE" against a classic cryotherapy "Nitrogen Liquid " to treat solar lentigines. The hands and the neckline will be randomised, either left or right side and treated by two cryotherapy devices: 1. CRYOTHERAPY MAINS ET DECOLLETE is the device under evaluation. 2. Liquid nitrogen is a comparator device.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cryobeauty trials

Trials by the same sponsor.

NCT03157427 — Clinical Evaluation of the Performance of a Difluoroethane-based Cyto-selective Cryotherapy to Treat Dark Spots on the H · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03225729 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cryobeauty
Last refreshed: 4 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03225729.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing